NHS Dudley Health Economy Medicines Formulary
Home > 6 Endocrine system > 6.6 Drugs affecting bone metabolism > 6.6.2 Bisphosphonates and other drugs affecting bone metabolism > Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) - NICE TAG TA549

Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) - NICE TAG TA549

NICE is unable to make a recommendation about the use in the NHS of denosumab for preventing skeletal-related events in multiple myeloma because no evidence submission was received from Amgen. We will review this decision if the company decides to make a submission.

https://www.nice.org.uk/guidance/ta549

Site by Devopa
© Copyright 2019 NHS. All rights reserved.